Literature DB >> 31220376

Pathomechanism of dupilumab-associated inflammatory eye symptoms.

J Wohlrab1,2, T Werfel3, A Wollenberg4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31220376     DOI： 10.1111/jdv.15755

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  4 in total

1.  Dupilumab-associated ulcerative keratitis.

Authors:  Matthew M Wilson; Philipp K Roberts; Mark Daniell
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

2.  Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis.

Authors:  Tamara Quint; Patrick M Brunner; Christoph Sinz; Irene Steiner; Robin Ristl; Kornelia Vigl; Susanne Kimeswenger; Katharina Neubauer; Detlev Pirkhammer; Martin Zikeli; Wolfram Hoetzenecker; Norbert Reider; Christine Bangert
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

Review 3.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

4.  Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process.

Authors:  Jacob P Thyssen; Steffen Heegaard; Lena Ivert; Anita Remitz; Tove Agner; Marjolein De Bruin-Weller; Theis Huldt-Nystrøm; Laura Korhonen; Lina U Ivert; Pekka Leinonen; Johanna Mandelin; Tore Särnhult; Thomas Schopf; Eirik Sundlisæter; Simon F Thomsen; Thrasyvoulos Tzellos; Christian Vestergaard; Laura von Kobyletzki; Maria Bradley
Journal:  Acta Derm Venereol       Date:  2020-09-16       Impact factor: 3.875
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.